Biotech & Pharma
Biotech and Pharma refer to the commercial sectors that develop, manufacture, and market products that use or intervene in biological processes. Multinational pharmaceutical companies have invested heavily in biotechnologies as a potential source of new drugs and devices. The biotech and pharma industries often oppose public oversight and regulation, despite their involvement in socially and ethically controversial products and activities. Because their involvement blurs the lines between private enterprise and public interest, biotech’s activities must be transparent and their interests acknowledged.
Published September 21, 2022
How should we talk about equity in the context of human genome editing? While sky-high costs and lack of access to potential somatic gene therapies are important to address, we also need to ask critical questions about health equity, sovereignty, and racial justice––particularly in relation to heritable genome editing, which would alter the genes and traits of future generations. This roundtable discussion with Indigenous geneticist-bioethicist Krystal Tsosie, reproductive justice scholar and advocate Dorothy Roberts, and educator and activist Milton Reynolds addresses the legacies of eugenics, honoring Indigenous sovereignty, decolonizing DNA, and why conversations about heritable genome editing urgently need voices and perspectives grounded in social justice and human rights. This discussion was hosted by Center for Genetics and Society and moderated by CGS associate director Katie Hasson.
Access a full transcript and learn more about the event and speakers at https://www.geneticsandsociety.org/in....
Published March 31, 2023
The third panel in CGS' Missing Voices Initiative webinar series, this roundtable conversation explored the perilous prospect of reproductive uses of human genome editing from the perspective of feminist and reproductive justice scholars and advocates. Their intersectional analyses illuminated concerns related to eugenics and the rapidly expanding global fertility industry. Speakers were Kavita Ramdas, Alana Cattapan, and Amrita Pande, and the panel was moderated by Susan Berke Fogel.
Find more information about the panel's speakers here: https://www.geneticsandsociety.org/in...
Learn more about CGS' Missing Voices Initiative here: https://www.geneticsandsociety.org/in...
Published March 2, 2023
This two-part online CGS event centers social justice and human rights, presenting voices and perspectives from feminist, disability rights, reproductive rights and justice, racial justice, environmental, and human rights movements and scholars, who question whether heritable genome editing has any place in a fair and inclusive future. Day 2 of the symposium includes two panels: "Missing voices speak out," featuring Larkin Taylor Parker, Abril Saldaña, Dana Perls, and Nourbese Flint, and moderated by Emily Galpern; and "Genetic justice beyond the summit," featuring Isabelle Bartram, Maria Ní Flatharta, Milton Reynolds, and Katie Hasson.
George Estreich discusses his most recent book Fables and Futures, inspired by his daughter Laura. Estreich goes beyond the personal to describe the ways that genetic technologies affect society and the stories the promoters of such technologies tell about them. The event took place on May 1, 2019 at the San Francisco Public Library.
